Neonatal hypoglycemia, confirmed by a plasma glucose level below the established threshold (typically <40-45 mg/dL in the first 24 hours and <50 mg/dL thereafter), was diagnosed in this neonate.  Risk factors for neonatal hypoglycemia identified in this patient include [Specify risk factor(s) e.g., maternal diabetes, prematurity, small for gestational age (SGA), large for gestational age (LGA), perinatal stress, or other relevant factors].  Presenting symptoms included [Specify symptoms if present e.g., jitteriness, tremors, hypotonia, lethargy, poor feeding, apnea, cyanosis, seizures, or irritability].  Initial plasma glucose measurement was [Insert value and time] mg/dL.  Treatment was initiated with [Specify treatment method e.g., breastfeeding, formula feeding, intravenous dextrose infusion] and the glucose levels were monitored closely.  Subsequent glucose levels were [Insert follow-up values and times] mg/dL.  The infant's response to treatment was [Describe response e.g., good, poor, requiring escalation of treatment].  The plan of care includes continued monitoring of blood glucose levels per protocol, [Specify frequency and duration] along with ongoing assessment for signs and symptoms of hypoglycemia.  Differential diagnoses considered included [Specify if applicable e.g., inborn errors of metabolism, sepsis].  Further investigations if required may include [Specify e.g., serum insulin levels, cortisol levels, growth hormone levels, metabolic screening].  Parent education was provided regarding the importance of recognizing and managing neonatal hypoglycemia.  The neonate's condition is currently stable, and the prognosis is [Insert current prognosis e.g., good, guarded] with ongoing monitoring and appropriate management.  This case of neonatal hypoglycemia was managed according to established clinical guidelines and best practices.